home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
TIME - Man of the Year
/
CompactPublishing-TimeMagazine-TimeManOfTheYear-Win31MSDOS.iso
/
moy
/
050492
/
05049918.000
< prev
next >
Wrap
Text File
|
1992-09-10
|
922b
|
26 lines
THE WEEK, Page 24HEALTH & SCIENCENew Drug for AIDS?
Accelerating the screening process, experts recommend approval
for DDC
The continuing ravages of AIDS have forced the U.S. Food and
Drug Administration to further streamline drug-approval
procedures. Last week a panel of experts recommended that the
government agency give its conditional blessing to
dideoxycytidine, or DDC. Although preliminary studies indicate
that this antiviral medication may not work as well as AZT which
still ranks as the premier AIDS treatment, the combination of
drugs seems to rejuvenate some of the immune cells that are
normally destroyed during the course of the disease.
If the FDA approves DDC the manufacturer, Hoffmann-La
Roche, will be required to submit further studies on the drug's
safety and efficacy.